Hirotaka Suto Yumiko Inui Atsuo Okamura
10.3389/fonc.2023.1158797
Front Oncol
2023 Apr 20;13:1158797.
ct fdg-pet her2 recist breast cancer liver metastasis
CC BY
https://pubmed.ncbi.nlm.nih.gov/37152012/
Case Reports
PMC10157226
37152012
Is CT or FDG-PET more useful for evaluation of the treatment response in metastatic HER2-positive breast cancer? a case report and literature review
2023